Marina Biotech Inc.
13F holders, Q2 2024 (June 30)2holders
0new positions
0sold out
$120.85avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Marina Biotech Inc. in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Byrne Asset Management LLC ($45K) and Huntington National Bank ($0).
- Company
- Marina Biotech Inc.
- CUSIP
- 56804Q201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 50 shares sold, net −50 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Byrne Asset Management LLC | 0.04% | Reduce -11.9% | 371 | $45K |
| Huntington National Bank | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is MARINA BIOTECH INC's weight in each manager's 13F, not the share of Marina Biotech Inc. the manager owns.